HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer.
about
Targeting caspases in cancer therapeuticsClinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer.Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.Cancer treatment: the combination of vaccination with other therapies.The functioning antigens: beyond just as the immunological targets.ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials.Survivin in solid tumors: rationale for development of inhibitors.Preclinical development of HIvax: Human survivin highly immunogenic vaccinesEnhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway.
P2860
Q26821986-BC4438CD-3F3F-48A0-9F0D-CA84B56295F5Q36725286-B8CF5068-DFAF-48BA-A7C4-B05AB5A6291BQ37064709-9A01393B-1C02-4492-90CE-3D00DCC62FB2Q37089001-112C3B8E-F70B-43BF-96BC-8B60F899585BQ37483795-534CDB27-F31A-4BB0-97EF-A63264E38300Q37512173-7F2962C8-F133-43F6-BC9A-101CD98DD95AQ37974867-B28548F6-806D-45E1-94EF-AA7DA6641991Q38867680-7174B5D9-DE3C-43B5-8523-AA82029136EAQ39637966-3FB70EAE-5C19-4F41-BC69-7824CC75D3BC
P2860
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer.
@en
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer.
@nl
type
label
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer.
@en
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer.
@nl
prefLabel
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer.
@en
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer.
@nl
P2860
P356
P1476
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer.
@en
P2093
Jürgen C Becker
Rikke B Soerensen
P2860
P2888
P356
10.1186/1479-5876-4-38
P577
2006-09-04T00:00:00Z
P5875
P6179
1030649693